Dissociation between early and late events in T cell activation mediated through CD28 surface molecule.
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
The regulation of early and late events of T cell activation via the CD28 molecule has been investigated, using as an indicator system the differentiated leukemic T cell line Jurkat. Both CD3 and CD28 mAbs induced an increase in (Ca2+)i in Jurkat cells, although with different kinetics, the latter being slower than the former. CD28-mediated (Ca2+)i mobilization was highly sensitive to cholera toxin (ID50 25 ng/ml, vs 300 ng/ml for CD3 stimulation). The inhibitory action of cholera toxin was neither merely due to the increase in intracellular cAMP concentrations, nor to decrease in cell surface expression of the CD28 molecule. To evaluate the effects of cholera toxin on late events of Jurkat cell activation induced by CD28 and CD3 mAbs, the action of cholera toxin and cAMP and CD3- and CD28-mediated IL-2 secretion was analyzed. CD3-induced IL-2 secretion was highly sensitive to cholera toxin (ID less than 5 ng/ml); on the other hand, CD28-induced IL-2 secretion was poorly sensitive to cholera toxin, in sharp contrast to (Ca2+)i mobilization. On the basis of these data, it is hypothesized that the CD28 pathway could be associated with at least two distinct transduction mechanisms, one responsible for the (Ca2+)i rise in Jurkat cells and highly sensitive to cholera toxin, and the other, whose second messenger is unknown, resistant to cholera toxin and responsible for IL-2 secretion.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Based on studies using cholera-toxin, it was suggested that conventional CD28 antibodies activate two functionally unrelated signaling pathways [22]. One of these pathways was found to be cholera-toxin sensitive, initiated transmembranous Ca++-flux, but did not influence IL-2 secretion whereas the other one was cholera-toxin insensitive and responsible for IL-2 production [22].”
From Signaling Signatures and Functional Properties of Anti-Human CD28 Superagonistic Antibodies (2008) · cites this paper as [22]
In the citing paper
“Moreover, despite costimulatory capacity, the same antibody that was used by Nunes et al. to dissect signaling events upon CD28-stimulation in Jurkat T cells (mAb 248.23.2 [22]) did not generate a detectable Ca++ signal in primary human T cells (data not shown).”
From Signaling Signatures and Functional Properties of Anti-Human CD28 Superagonistic Antibodies (2008) · cites this paper as [22]
Citations
Cites
Meuer, S. C., Hussey, R. E., Fabbi, M., Fox, D., Acuto, O., Fitzgerald, K. A., Hodgdon, J. C., Protentis, J. P., Schlossman, S. F., & Reinherz, E. L. (1984) · Cell · doi:10.1016/0092-8674(84)90039-4 · Cited by 1,113
Cassel, D., & Pfeuffer, T. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.6.2669 · Cited by 907
Regulation of Lymphokine Messenger RNA Stability by a Surface-Mediated T Cell Activation Pathway
Lindstein, T., June, C. H., Ledbetter, J. A., Stella, G., & Thompson, C. B. (1989) · Science · doi:10.1126/science.2540528 · Cited by 878
Gill, D. M., & Meren, R. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.7.3050 · Cited by 735
Imboden, J. B., & Stobo, J. D. (1985) · The Journal of experimental medicine · doi:10.1084/jem.161.3.446 · Cited by 729
June, C. H., Ledbetter, J. A., Gillespie, M. M., Lindsten, T., & Thompson, C. B. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.12.4472 · Cited by 566
June, C. H., Fletcher, M. C., Ledbetter, J. A., & Samelson, L. E. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.5.1591 · Cited by 421
Rabinovitch, P. S., June, C. H., Grossmann, A., & Ledbetter, J. A. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.137.3.952 · Cited by 362
Hara, T., Fu, S. M., & Hansen, J. A. (1985) · The Journal of experimental medicine · doi:10.1084/jem.161.6.1513 · Cited by 278
Ledbetter, J. A., June, C. H., Grosmaire, L. S., & Rabinovitch, P. S. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.5.1384 · Cited by 217
Imboden, J. B., Shoback, D. M., Pattison, G., & Stobo, J. D. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.15.5673 · Cited by 199
Martin, P. J., Ledbetter, J. A., Morishita, Y., June, C. H., Beatty, P. G., & Hansen, J. A. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.9.3282 · Cited by 196
Regulation of interleukin 2 synthesis by cAMP in human T cells.
Mary, D., Aussel, C., Ferrua, B., & Fehlmann, M. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.4.1179 · Cited by 196
Ledbetter, J. A., Parsons, M., Martin, P. J., Hansen, J. A., Rabinovitch, P. S., & June, C. H. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.137.10.3299 · Cited by 166
Synergy between the T3/antigen receptor complex and Tp44 in the activation of human T cells.
Weiss, A., Manger, B., & Imboden, J. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.137.3.819 · Cited by 163
Brottier, P., Boumsell, L., Gélin, C., & Bernard, A. (1985) · The Journal of Immunology · doi:10.4049/jimmunol.135.3.1624 · Cited by 153
Pantaleo, G., Olive, D., Poggi, A. D., Kozumbo, W. J., Moretta, L., & Moretta, A. (1987) · European Journal of Immunology · doi:10.1002/eji.1830170110 · Cited by 143
Self-citationMoretta, A., Pantaleo, G., Lopez-Botet, M., & Moretta, L. (1985) · The Journal of experimental medicine · doi:10.1084/jem.162.3.823 · Cited by 142
Ledbetter, J. A., June, C. H., Martin, P. J., Spooner, C. E., Hansen, J. A., & Meier, K. E. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.11.3945 · Cited by 140
Lerner, A., Jacobson, B. A., & Miller, R. A. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.140.3.936 · Cited by 126
van Lier, R. A. W., Brouwer, M., & Aarden, L. A. (1988) · European Journal of Immunology · doi:10.1002/eji.1830180125 · Cited by 125
Olive, D., Ragueneau, M., Cerdan, C., Dubreuil, P. C., Lopez, M., & Mawas, C. E. (1986) · European Journal of Immunology · doi:10.1002/eji.1830160906 · Cited by 85
Self-citationDustin, M. L., Olive, D., & Springer, T. A. (1989) · The Journal of Experimental Medicine · doi:10.1084/jem.169.2.503 · Cited by 84
Self-citationMoretta, A., Poggi, A. D., Olive, D., Bottino, C., Fortis, C., Pantaleo, G., & Moretta, L. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.6.1654 · Cited by 81
Self-citationTriggering CD 28 molecules synergize with CD 2 (T11.1 and T11,2)‐mediated T cell activation
Pierrès, A., Lopez, M., Cerdan, C., Nunès, J. A., Olive, D., & Mawas, C. E. (1988) · European Journal of Immunology · doi:10.1002/eji.1830180505 · Cited by 51
Self-citationBjorndahl, J. M., Sung, S. J., Hansen, J. A., & Fu, S. M. (1989) · European Journal of Immunology · doi:10.1002/eji.1830190515 · Cited by 48
Bagnasco, M., Nunès, J. A., Lopez, M., Cerdan, C., Pierrès, A., Mawas, C. E., & Olive, D. (1989) · European Journal of Immunology · doi:10.1002/eji.1830190507 · Cited by 32
Self-citationPantaleo, G., Olive, D., Harris, D., Poggi, A., Moretta, L., & Moretta, A. (1986) · European Journal of Immunology · doi:10.1002/eji.1830161228 · Cited by 28
Self-citationNunès, J. A., Bagnasco, M., Lopez, M., Olive, D., & Mawas, C. E. (1989) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240390405 · Cited by 8
Self-citation
Research works printed but not linked: 1
- Mary, 1991, Prostaglandin E2 is involved in the biological effects of interleukin-1 in human T cells, EMBO J. Immun.
Cited by
The Role of the CD28 Receptor During T Cell Responses to Antigen
Linsley, P. S., & Ledbetter, J. A. (1993) · Annual Review of Immunology · doi:10.1146/annurev.iy.11.040193.001203 · Cited by 1,298
The B7 and CD28 receptor families
June, C. H., Bluestone, J. A., Nadler, L. M., & Thompson, C. B. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90080-9 · Cited by 1,296
Effect of CD28 signal transduction on c-Rel in human peripheral blood T cells.
Bryan, R. G., Li, Y., Lai, J. H., Van, M., Rice, N. R., Rich, R. R., & Tan, T. H. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.12.7933 · Cited by 87
Signaling Signatures and Functional Properties of Anti-Human CD28 Superagonistic Antibodies
Waibler, Z., Sender, L. Y., Merten, C., Hartig, R., Kliche, S., Gunzer, M., Reichardt, P., Kalinke, U., & Schraven, B. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001708 · Cited by 79
“These differences might be due to the different cells that were investigated or to different CD28 antibody preparations (ascites fluid in [22] vs.”
BackgroundInfluentialNunès, J. A., Klasen, S., Franco, M.-D., Lipcey, C., Mawas, C. E., Bagnasco, M., & Olive, D. (1993) · Biochemical Journal · doi:10.1042/bj2930835 · Cited by 46
Self-citation
Metadata
- Authors
- Nunes, J., Bagnasco, M., Lopez, M., Lipcey, C., Mawas, C., & Olive, D.
- Affiliations
- Inserm (FR)
- Venue
- Molecular Immunology
- Publisher
- Elsevier BV
- Published
- 1991-04
- Volume
- 28
- Issue
- 4-5
- Pages
- 427-435
- ISSN
- 0161-5890 (ISSN-L)
- OpenAlex
- W2059779941
- Cited by
- 9
- References
- 29
- Citations by year
- 2015: 1
- FWCI
- 0.87
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Molecular Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- T cell activation, CD28, CD3, Jurkat cells, calcium mobilization, cholera toxin, cyclic AMP, interleukin-2 secretion, signal transduction, T cell differentiation
- MeSH terms
- Cyclic AMP, Antibodies, Monoclonal, Antigens, Differentiation, T-Lymphocyte, Calcium, Cholera Toxin, Colforsin, Humans, Interleukin-2, Lymphocyte Activation, Receptors, Antigen, T-Cell, Receptors, Immunologic, T-Lymphocytes, Time Factors, Tumor Cells, Cultured, Signal Transduction, Down-Regulation, Antigens, CD, CD3 Complex, CD28 Antigens, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.